Current issues in the treatment of bronchial asthma


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article discusses the current understanding of the treatment of bronchial asthma, one of the most widespread and socially significant diseases in the world. The issues of control of the diseases, training and long-term management of patients are discussed. The basic groups of drugs currently recommended for management of adult asthmatic patients with stable course of disease are presented. Stepwise therapy of bronchial asthma is considered. The data on new drugs recommended for the treatment of the disease in recent years are presented.

Full Text

Restricted Access

About the authors

A. V Emelyanov

FSBEI HE “North-Western State Medical University n.a. I.I. Mechnikov" of RMH

Email: aleksandr.emelyanov@szgmu.ru
MD, Prof., Head of the Department of Pulmonology

E. V Leshenkova

FSBEI HE “North-Western State Medical University n.a. I.I. Mechnikov" of RMH

Department of Pulmonology

G. R Sergeeva

FSBEI HE “North-Western State Medical University n.a. I.I. Mechnikov" of RMH

Department of Pulmonology

References

  1. Global Strategy for Asthma Management and Prevention. Revised 2016. https://www. glnasthma.org (доступ 13.02.17).
  2. Chuchalin A.G., Khaltaev N., Аntonov N. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. COPD. 2014;19:963-74.
  3. Сергеева Г.Р., Емельянов А.В., Федосеев Г.Б. и др. Распространенность бронхиальной астмы и аллергического ринита среди взрослого населения Санкт-Петербурга. Тер. архив 2003;75(1):23-6.
  4. Бронхиальная астма. Клинические рекомендации Российского респираторного общества, 2016 г. http://www.pulmonology.ru (доступ 13.02.2016).
  5. Аллергология. Клинические рекомендации / Под ред. Р.М. Хаитова, Н.И. Ильиной. М., 2009. C. 204-21.
  6. Williams L.K., Peterson L.E., Wells K., Ahmedani B.K., Kumar R., Burchard E.G., Chowdhry V.K., Favro D., Lanfear D.E., Pladevall M. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroids nonadherence. J. Allergy Clin. Immunol. 2011;128(6): 1185-91.
  7. Barnes P.J. Scientific rationale for using single inhaler for asthma control. Eur. Respir. J. 2007;29(3):587-95.
  8. Irwin R.S., Richardson N.D. Side effects with inhaled corticosteroids. Chest. 2006;130(Suppl. 1):41-53.
  9. Bousquet J., van Cauwenberge P., Khaltaev N., et al. Allergic rhinitis and its impact on asthma (ARIA). ARIA. At a glance pocket reference, 1st Edition, 2007. 6 p.
  10. Wang L., Yin J., Fadel R., Montagut A., de Beaumont O., Devillier P. House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma. Allergy. 2014;9:1181-89.
  11. Virchow C., Backer V., Kuna P., Prieto L., Nolte H., Villesen H.H., Ljørring C., Riis B., de Blay F. Efficacy of house dust mite allergen sublingual immunotherapy tablets in adults patients with allergic asthma: a randomized clinical trial. JAMA. 2016;315(16): 1715-25.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bionika Media